Popular Articles

Some Experts Remain Skeptical Of Withdrawal Method, Despite Recent Study On Effectiveness
Reproductive health experts were "taken aback" by a recent study that found that the withdrawal method is nearly as effective as male condoms in preventing pregnancy, the New York Times reports. The paper -- published in the June issue of the journal Contraception -- found that 4% of couples will become pregnant over a one-year period if they consistently use the withdrawal method, compared with about 2% of couples that consistently use condoms. According to the study"s authors, a more significant finding was that the rate of "typical use" for withdrawal leads to pregnancy 18% of the time, compared with 17% of the time for typical use of condoms. They wrote in the study that "it is unfortunate that some couples do not realize they are substantially reducing their risk of pregnancy when using withdrawal, as these misperceptions may cause unnecessary levels of anxiety. More speculatively, if more people realized that correct and consistent use of withdrawal substantially reduced the risk of pregnancy, they might use it more effectively." Although the authors said the goal of the paper was to encourage discussion, some experts are concerned that spreading a message that withdrawal is effective could lead young people to have unprotected sex, potentially exposing themselves to sexually transmitted infections that can be prevented through condom use, the Times reports. Melissa Gilliam, chief of family planning and contraceptive research at the University of Chicago"s Department of Obstetrics and Gynecology and a board member of the Guttmacher Institute, said the study"s data "don"t necessarily translate to youth today." She added, "In terms of a reliable method used over and over again, the risk of failure is quite high."Rachel Jones, the lead author of the study and a senior research associate at Guttmacher, said that dismissing the withdrawal method as a "legitimate" form of contraception is "counterproductive for the prevention of pregnancy and also discourages academic inquiry into this frequently used and reasonably effective method." She also said that health educators and providers "should discuss withdrawal as a legitimate, if slightly less effective, contraceptive method in the same way they do condoms and diaphragms." She noted that "most women have used withdrawal at some point in their lives."The study"s authors decided to examine the issue after noticing that many researchers and providers "just kind of dismiss withdrawal and don"t seem to realize that it can prevent pregnancy," according to Jones. She added, "Most people seem to be under the impression that you might as well do nothing." Martha Kempner, vice president for information and communications at the Sexuality Information and Education Council of the United States, said the results of the study have "made some classroom teachers nervous to give out the truth in this instance, but we do have to tell the truth." She added, "People, kids in particular, they"re using it. It is better than nothing, and it is always available" (Belluck, New York Times, 7/21).
generic viagra online
Team Uncovers The Molecular Basis For The Regulation Of Blood Clotting
By applying cutting-edge techniques in single-molecule manipulation, researchers at Harvard University have uncovered a fundamental feedback mechanism that the body uses to regulate the clotting of blood. The finding, which could lead to a new physical, quantitative, and predictive model of how the body works to respond to injury, has implications for the treatment of bleeding disorders.
News of the day
Law Study To Improve Doctors' End-Of-Life Decisions
More than 13,000 people who have lost the ability to make their own decisions die in Queensland, Victoria and New South Wales each year after doctors have withheld life-sustaining medical treatment such as CPR.
Sexual Health

Health Canada Informs Pregnant And Breastfeeding Women Not To Take Vitamin Maxum Matragen And/or Maxum Multi Vite Supplements

Health Canada is advising expectant mothers and breastfeeding women not to take the vitamin-mineral supplements Maxum Matragen or Maxum Multi-Vite by Seroyal International Inc. Maxum Multi-Vite has been approved as a vitamin-mineral supplement for only the general public but lacks the required cautionary statement on the label regarding pregnant and/or breast feeding women. The product Maxum Matragen is being promoted by the company as a prenatal supplement; however, neither product has been authorized for sale by Health Canada for use by women who are pregnant or breastfeeding. Both products contain ingredients such as Ginkgo biloba, Green Tea Extracts and Vanadium, whose safe use during pregnancy or in breastfeeding women has not been well established. Products containing these ingredients require a cautionary label warning consumers to consult with a health care practitioner prior to use if they are pregnant or breastfeeding, neither Maxum Matragen nor Maxum Multi-Vite carries such a warning on their labels. In addition, the daily doses as labelled for Maxum Matragen and Maxum Multi Vite do not provide the minimum recommended daily dose of 400 mcg of folic acid and the recommended 16-20 mg of iron for expectant, pregnant and breastfeeding women. Health Canada has not received any adverse reaction reports associated with Maxum Matragen and/or Maxum Multi-Vite. Pregnant or breastfeeding women who may be taking Maxum Matragen or Maxum Multi-Vite are advised to consult their health care professional prior to continuing use of these products. The company Seroyal International Inc. has voluntarily recalled these products from the market. Please visit the Public Health Agency of Canada"s website for more information on healthy living during pregnancy. Consumers requiring more information about this advisory can contact Health Canada"s public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709. You can report any adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways: Report online at the MedEffect™ Canada Web site Call toll-free at 1-866-234-2345 Complete a Canada Vigilance Reporting Form and either: Fax toll-free to 1-866-678-6789 Mail to: Canada Vigilance Program Health Canada AL 0701C Ottawa, ON K1A 0K9 Health Canada


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):